Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| REGN | Regeneron Pharmaceuticals, Inc. | -1.79% | 556.92 | 2.7% | $639.83m | |
| GILD | Gilead Sciences, Inc. | -0.15% | 58.64 | 1.0% | $576.83m | |
| AMGN | Amgen, Inc. | 0.99% | 218.53 | 1.3% | $572.65m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.24% | 207.85 | 1.9% | $532.91m | |
| MRNA | Moderna, Inc. | 8.73% | 71.48 | 0.0% | $451.78m | |
| ILMN | Illumina, Inc. | 2.08% | 316.14 | 3.5% | $405.51m | |
| EXAS | EXACT Sciences Corp. | -5.46% | 120.56 | 20.7% | $281.36m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 3.25% | 118.58 | 2.0% | $268.25m | |
| NVAX | Novavax, Inc. | 7.73% | 87.62 | 96.5% | $256.80m | |
| BIIB | Biogen, Inc. | 1.02% | 246.75 | 1.7% | $253.65m | |
| BNTX | BioNTech SE | 9.61% | 84.99 | 0.0% | $217.19m | |
| SRRK | Scholar Rock Holding Corp. | -5.71% | 40.95 | 0.0% | $164.99m | |
| SGEN | Seagen Inc. | -1.10% | 192.72 | 6.0% | $143.37m | |
| SRNE | Sorrento Therapeutics, Inc. | 2.90% | 7.30 | 1.4% | $139.52m | |
| CRSP | CRISPR Therapeutics AG | 1.99% | 96.59 | 0.6% | $125.83m |
Company Profile
Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. It operates through the Research & Development and Fee-for-Services segment. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.